News

An interview with Sheldon Rowan, PhD, about how diet and microbiomes impact age-related macular degeneration.

Working to save sight, BrightFocus’ National Glaucoma Research program is supporting Kathryn Burdon, PhD, of Australia’s University of Tazmania and Girum Gessesse, MD, of Ethiopia’s St. Paul’s Hospital Millennium Medical College to expand our scientific understanding of glaucoma in Africa.

BrightFocus-supported research by Tal Nuriel, PhD, raises important questions after documenting that the APOE4 allele impacts cell bioenergetics in the entorhinal cortex, a critical brain region first damaged in Alzheimer’s disease.

In this issue: New FDA-Approved Long-Term Glaucoma Treatment, President’s Corner, The Benefits and Risks of Glaucoma Surgery, Spotlight On … Haiyan Gong, MD, PhD, And More!

Read about scientists describing how the protein tau is modified over four decades as Alzheimer’s develops and progresses.

New partnerships with BrightFocus Foundation and CURE will promote research, clinical trials in neurology practices nationwide.